Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Emergence of a Novel Recombinant Norovirus GII.P16-GII.12 Strain Causing Gastroenteritis, Alberta, Canada.

Pabbaraju K, Wong AA, Tipples GA, Pang XL.

Emerg Infect Dis. 2019 Aug;25(8):1556-1559. doi: 10.3201/eid2508.190059.

2.

Changes in norovirus genotype diversity in gastroenteritis outbreaks in Alberta, Canada: 2012-2018.

Hasing ME, Lee BE, Qiu Y, Xia M, Pabbaraju K, Wong A, Tipples G, Jiang X, Pang XL.

BMC Infect Dis. 2019 Feb 19;19(1):177. doi: 10.1186/s12879-019-3792-y.

3.

Simultaneous Detection and Differentiation between Wild-Type and Vaccine Measles Viruses by a Multiplex Real-Time Reverse Transcription-PCR Assay.

Pabbaraju K, Gill K, Wong AA, Tipples GA, Hiebert J, Severini A, Fonseca K, Tellier R.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01828-18. doi: 10.1128/JCM.01828-18. Print 2019 Apr.

4.

Diagnostic Interpretation Guidance for Pediatric Enteric Pathogens: A Modified Delphi Consensus Process.

Stang AS, Trudeau M, Vanderkooi OG, Lee BE, Chui L, Pang XL, Allen V, Burnham CD, Goldfarb DM, MacDonald J, Parsons B, Petrich A, Pollari F, Tarr PI, Tipples G, Zhuo R, Freedman SB.

Can J Infect Dis Med Microbiol. 2018 Sep 27;2018:2589826. doi: 10.1155/2018/2589826. eCollection 2018.

5.

Genetic characterization of measles virus genotype D6 subacute sclerosing panencephalitis case, Alberta, Canada.

Pabbaraju K, Fonseca K, Wong S, Koch MW, Joseph JT, Tipples GA, Tellier R.

J Neurovirol. 2018 Dec;24(6):720-729. doi: 10.1007/s13365-018-0668-7. Epub 2018 Oct 5.

PMID:
30291564
6.

Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa.

German GJ, Gilmour M, Tipples G, Adam HJ, Almohri H, Bullard J, Dingle T, Farrell D, Girouard G, Haldane D, Hoang L, Levett PN, Melano R, Minion J, Needle R, Patel SN, Rennie R, Reyes RC, Longtin J, Mulvey MR.

Can Commun Dis Rep. 2018 Jan 4;44(1):29-34. eCollection 2018 Jan 4.

7.

Hepatitis A virus infection associated with cannabis use.

Sikora C, Tipples G, Pang XL, Andonov A.

Can Commun Dis Rep. 2017 Nov 2;43(11):245-246. eCollection 2017 Nov 2.

8.

Simultaneous detection of Zika, Chikungunya and Dengue viruses by a multiplex real-time RT-PCR assay.

Pabbaraju K, Wong S, Gill K, Fonseca K, Tipples GA, Tellier R.

J Clin Virol. 2016 Oct;83:66-71. doi: 10.1016/j.jcv.2016.09.001. Epub 2016 Sep 1.

PMID:
27614319
9.

Full genome analysis of enterovirus D-68 strains circulating in Alberta, Canada.

Pabbaraju K, Wong S, Drews SJ, Tipples G, Tellier R.

J Med Virol. 2016 Jul;88(7):1194-203. doi: 10.1002/jmv.24444. Epub 2015 Dec 22.

PMID:
26643129
10.

Detection of enterovirus D68 in Canadian laboratories.

Hatchette TF, Drews SJ, Grudeski E, Booth T, Martineau C, Dust K, Garceau R, Gubbay J, Karnauchow T, Krajden M, Levett PN, Mazzulli T, McDonald RR, McNabb A, Mubareka S, Needle R, Petrich A, Richardson S, Rutherford C, Smieja M, Tellier R, Tipples G, LeBlanc JJ.

J Clin Microbiol. 2015 May;53(5):1748-51. doi: 10.1128/JCM.03686-14. Epub 2015 Mar 4.

11.

Characterization of enterovirus activity, including that of enterovirus D68, in pediatric patients in Alberta, Canada, in 2014.

Drews SJ, Simmonds K, Usman HR, Yee K, Fathima S, Tipples G, Tellier R, Pabbaraju K, Wong S, Talbot J.

J Clin Microbiol. 2015 Mar;53(3):1042-5. doi: 10.1128/JCM.02982-14. Epub 2015 Jan 14. No abstract available.

12.

Determining rubella immunity in pregnant Alberta women 2009-2012.

Lai FY, Dover DC, Lee B, Fonseca K, Solomon N, Plitt SS, Jaipaul J, Tipples GA, Charlton CL.

Vaccine. 2015 Jan 29;33(5):635-41. doi: 10.1016/j.vaccine.2014.12.022. Epub 2014 Dec 19.

PMID:
25533327
13.

Comparison of the IMDx influenza A virus, influenza B virus, and respiratory syncytial virus A/B assay on the m2000 platform with real-time reverse transcriptase PCR assays.

Adachi D, Tang JW, Lundeberg R, Tipples G, Charlton CL, Drews SJ.

J Clin Microbiol. 2014 Dec;52(12):4441-2. doi: 10.1128/JCM.02565-14. Epub 2014 Oct 1. No abstract available.

14.

Discrepant HIV results resolved by human DNA testing.

Tang JW, Adachi D, Gunning H, Marian-Dyer C, Hume S, Taylor S, Haase S, Vicen L, Benedet M, Chow A, Somerville M, Hicks M, Tipples G.

J Clin Virol. 2014 Oct;61(2):311-2. doi: 10.1016/j.jcv.2014.06.021. Epub 2014 Jun 30.

PMID:
25067806
15.

Full-genome analysis of avian influenza A(H5N1) virus from a human, North America, 2013.

Pabbaraju K, Tellier R, Wong S, Li Y, Bastien N, Tang JW, Drews SJ, Jang Y, Davis CT, Fonseca K, Tipples GA.

Emerg Infect Dis. 2014 May;20(5):887-91. doi: 10.3201/eid2005.140164.

16.

Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes.

Chow VT, Tipples GA, Grose C.

Infect Genet Evol. 2013 Aug;18:351-6. doi: 10.1016/j.meegid.2012.11.008. Epub 2012 Nov 24.

17.

Results of continuous monitoring of the performance of rubella virus IgG and hepatitis B virus surface antibody assays using trueness controls in a multicenter trial.

Kruk T, Ratnam S, Preiksaitis J, Lau A, Hatchette T, Horsman G, Van Caeseele P, Timmons B, Tipples G.

Clin Vaccine Immunol. 2012 Oct;19(10):1624-32. Epub 2012 Aug 15.

18.

Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009.

Wielders CC, van Binnendijk RS, Snijders BE, Tipples GA, Cremer J, Fanoy E, Dolman S, Ruijs Wl, Boot HJ, de Melker HE, Hahne SJ.

Euro Surveill. 2011 Oct 13;16(41). pii: 19989.

19.

Rubella diagnostic issues in Canada.

Tipples GA.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S659-63. doi: 10.1093/infdis/jir430.

PMID:
21954263
20.

Rubella elimination, the Canadian experience.

Macey JF, Tam T, Lipskie T, Tipples G, Eisbrenner T.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S585-92. doi: 10.1093/infdis/jir406.

PMID:
21954251
21.

Detection of measles, mumps, and rubella viruses.

Tipples G, Hiebert J.

Methods Mol Biol. 2011;665:183-93. doi: 10.1007/978-1-60761-817-1_11.

PMID:
21116802
22.
23.

Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons.

Dallaire F, De Serres G, Tremblay FW, Markowski F, Tipples G.

J Infect Dis. 2009 Nov 15;200(10):1602-5. doi: 10.1086/644783.

PMID:
19827945
24.

Rubella outbreak in the Netherlands, 2004-2005: high burden of congenital infection and spread to Canada.

Hahné S, Macey J, van Binnendijk R, Kohl R, Dolman S, van der Veen Y, Tipples G, Ruijs H, Mazzulli T, Timen A, van Loon A, de Melker H.

Pediatr Infect Dis J. 2009 Sep;28(9):795-800. doi: 10.1097/INF.0b013e3181a3e2d5.

PMID:
19710586
25.

Aplastic anemia following varicella vaccine.

Angelini P, Kavadas F, Sharma N, Richardson SE, Tipples G, Roifman C, Dror Y, Nofech-Mozes Y.

Pediatr Infect Dis J. 2009 Aug;28(8):746-8. doi: 10.1097/INF.0b013e31819b6c1f.

PMID:
19633522
26.

Parotitis in a child infected with triple-reassortant influenza A virus in Canada in 2007.

Bastien N, Bowness D, Burton L, Bontovics E, Winter AL, Tipples G, Minielly D, Gregg B, Cramer C, Schincariol C, Li Y.

J Clin Microbiol. 2009 Jun;47(6):1896-8. doi: 10.1128/JCM.01684-08. Epub 2009 Apr 1.

27.

Detection of mumps virus RNA by real-time one-step reverse transcriptase PCR using the LightCycler platform.

Leblanc JJ, Pettipas J, Davidson RJ, Tipples GA, Hiebert J, Hatchette TF.

J Clin Microbiol. 2008 Dec;46(12):4049-51. doi: 10.1128/JCM.01446-08. Epub 2008 Oct 22.

28.

Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.

Ota K, Kim V, Lavi S, Ford-Jones EL, Tipples G, Scolnik D, Tellier R.

Pediatr Infect Dis J. 2008 Sep;27(9):847-8. doi: 10.1097/INF.0b013e318170af75.

PMID:
18664930
29.

Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.

Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL.

Pediatr Infect Dis J. 2008 Jan;27(1):75-7. Review.

PMID:
18162946
30.

Application of DNA array technology for diagnostic microbiology.

Booth SA, Drebot MA, Tipples GA, Ng LK.

Can J Infect Dis. 2000 Nov;11(6):291-4. No abstract available.

31.

A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection.

Humar A, Kumar D, Gray M, Moussa G, Venkataraman S, Kumar R, Tipples GA.

Transplantation. 2007 May 15;83(9):1200-6.

PMID:
17496536
32.

Identical genotype B3 sequences from measles patients in 4 countries, 2005.

Rota J, Lowe L, Rota P, Bellini W, Redd S, Dayan G, van Binnendijk R, Hahné S, Tipples G, Macey J, Espinoza R, Posey D, Plummer A, Bateman J, Gudiño J, Cruz-Ramirez E, Lopez-Martinez I, Anaya-Lopez L, Holy Akwar T, Giffin S, Carrión V, de Filippis AM, Vicari A, Tan C, Wolf B, Wytovich K, Borus P, Mbugua F, Chege P, Kombich J, Akoua-Koffi C, Smit S, Bukenya H, Bwogi J, Baliraine FN, Kremer J, Muller C, Santibanez S.

Emerg Infect Dis. 2006 Nov;12(11):1779-81.

33.

Evaluation of commercial rubella immunoglobulin G avidity assays.

Mubareka S, Richards H, Gray M, Tipples GA.

J Clin Microbiol. 2007 Jan;45(1):231-3. Epub 2006 Nov 8.

34.

Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences.

Tyler SD, Peters GA, Grose C, Severini A, Gray MJ, Upton C, Tipples GA.

Virology. 2007 Mar 15;359(2):447-58. Epub 2006 Oct 25.

36.

Prevention of congenital rubella syndrome--what makes sense in 2006?

Robinson JL, Lee BE, Preiksaitis JK, Plitt S, Tipples GA.

Epidemiol Rev. 2006;28:81-7. Epub 2006 Jun 14. Review.

PMID:
16775038
37.

Rubella outbreak in an unvaccinated religious community in the Netherlands spreads to Canada.

Hahné S, Macey J, Tipples G, Varughese P, King A, van Binnendijk R, Ruijs H, van Steenbergen J, Timen A, van Loon AM, de Melker H.

Euro Surveill. 2005 May 19;10(5):E050519.1. No abstract available.

PMID:
16766825
38.

Use of the next generation pharmaceutical impactor for particle size distribution measurements of live viral aerosol vaccines.

Leung K, Louca E, Gray M, Tipples G, Coates AL.

J Aerosol Med. 2005 Winter;18(4):414-26.

PMID:
16379617
39.

How many infective viral particles are necessary for successful mass measles immunization by aerosol?

Coates AL, Tipples G, Leung K, Gray M, Louca E; WHO Product Development Group for Measles Aerosol Vaccine.

Vaccine. 2006 Mar 6;24(10):1578-85. Epub 2005 Oct 18.

PMID:
16266775
40.

Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.

Loparev VN, Gonzalez A, Deleon-Carnes M, Tipples G, Fickenscher H, Torfason EG, Schmid DS.

J Virol. 2004 Aug;78(15):8349-58.

41.
42.

Evaluation of rubella IgM enzyme immunoassays.

Tipples GA, Hamkar R, Mohktari-Azad T, Gray M, Ball J, Head C, Ratnam S.

J Clin Virol. 2004 Jul;30(3):233-8.

PMID:
15135741
43.

Measles elimination in Canada.

King A, Varughese P, De Serres G, Tipples GA, Waters J; Working Group on Measles Elimination.

J Infect Dis. 2004 May 1;189 Suppl 1:S236-42.

PMID:
15106117
44.

Genotyping of measles virus in Canada: 1979-2002.

Tipples GA, Gray M, Garbutt M, Rota PA; Canadian Measles Surveillance Program.

J Infect Dis. 2004 May 1;189 Suppl 1:S171-6.

PMID:
15106107
45.

Molecular epidemiology of measles virus in Kenya.

Mbugua FM, Okoth FA, Gray M, Kamau T, Kalu A, Eggers R, Borus P, Kombich J, Langat A, Maritim P, Lesiamon J, Tipples GA.

J Med Virol. 2003 Dec;71(4):599-604.

PMID:
14556275
46.
47.

Assessment of immunoglobulin M enzyme immunoassays for diagnosis of measles.

Tipples GA, Hamkar R, Mohktari-Azad T, Gray M, Parkyn G, Head C, Ratnam S.

J Clin Microbiol. 2003 Oct;41(10):4790-2.

48.

Structure of replicating intermediates of human herpesvirus type 6.

Severini A, Sevenhuysen C, Garbutt M, Tipples GA.

Virology. 2003 Sep 15;314(1):443-50.

49.

Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase.

Safronetz D, Petric M, Tellier R, Parvez B, Tipples GA.

J Med Virol. 2003 Nov;71(3):434-9.

PMID:
12966551
50.

Differentiation and quantitation of human herpesviruses 6A, 6B and 7 by real-time PCR.

Safronetz D, Humar A, Tipples GA.

J Virol Methods. 2003 Sep;112(1-2):99-105.

PMID:
12951217

Supplemental Content

Loading ...
Support Center